FDA And Drug Manufacturer Issue Recall Due To Contamination

by | January 11th, 2013

January 11, 2013

The U.S. Food and Drug Administration (FDA) announced earlier this week that it had partnered with Mobius Therapeutics, LLC, in issuing a voluntary market recall of the company’s Mitosol® (mitomycin for solution), 0.2 mg/vial, kit for ophthalmic use. According to a press release from the agency, the recall was issued due to a possible contamination of two lots of the medication.

Doctors and surgeons in hospitals and clinics where a certain type of glaucoma surgery is performed use the product. Experts say the recall is being issued due to lots M098260 and M086920 being found to contain a strain of yeast that could cause a serious Drug Injury. Experts say use of a contaminated dose could result in severe eye problems and infections that could lead to potential blindness. Units of the contaminated medication were shipped to more than 20 states across the nation.

Mobius has both conducted an investigation to get to the root of the contamination and has also contacted any company that purchased part of the contaminated lots of drugs. Anyone still in possession of affected medications has been instructed to halt use of the drugs immediately and to contact the manufacturer about receiving replacements and disposing of the contaminated drugs.

The Ohio Personal Injury Lawyers with Nurenberg, Paris, Heller & McCarthy recognize the dangers of medical professionals using contaminated medications on patients and suggest looking into your legal rights if a drug prescribed and administered to you by a doctor has harmed you.